Validation of the Spanish version of the QoL-AD scale in Alzheimerdisease patients, their carers, and health professionals.

Gómez Amor, Jesús; Gómez García, Juan; Gómez Gallego, María

Publication:
Validation of the Spanish version of the QoL-AD scale in Alzheimerdisease patients, their carers, and health professionals.

dc.contributor.author	Gómez Amor, Jesús
dc.contributor.author	Gómez García, Juan
dc.contributor.author	Gómez Gallego, María
dc.contributor.department	Atención Sociosanitaria
dc.date.accessioned	2024-07-26T10:32:34Z
dc.date.available	2024-07-26T10:32:34Z
dc.date.issued	2012-02-09
dc.description	© 2010 Sociedad Española de Neurología. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/ This document is the Published version of a Published Work that appeared in final form in Neurología (English Edition). To access the final edited and published work see https://doi.org/10.1016/j.nrleng.2011.03.005
dc.description.abstract	Background: Quality of life (QOL) is becoming increasingly important to measure the effect of interventions on the life of patients with Alzheimer’s disease (AD), particularly on the most meaningful issues. However, most of the instruments used to measure QOL have not been validated in the Spanish population. The aim of this study was to determine the psychometric properties of a Spanish version of QoL scale in patients with AD, carers and health professionals. Material and methods: On hundred and two patients, their carers and 25 health professionals were recruited from day centres. Patients’ QOL was rated by patients, carers and health professionals. The Health Utilities Index, Clinical Insight Rating Scale and Mini Mental State Examination were also administered. Results: The internal reliability and external reliability of QoL-AD were excellent. Criterion validity was indicated by a significant correlation of QoL-AD scores with HUI-3 and QoL-AD global item scores (P < .05). Lack of insight and cognitive impairment did not have an effect on these properties. QoL-AD scores were not significantly different between groups made according sociodemographic characteristics and cognitive impairment (P > .05). The exploratory factor analysis result revealed a three factor solution, which accounted for 61.3% of variance: health factor, functional status factor, and social relationship environment factor. Conclusions: QoL-AD scale has proved to be a valid and reliable instrument to measure QoL of Spanish AD patients with mild-to-moderate cognitive impairment and a wide range of anosognosia.	es
dc.format	application/pdf	es
dc.format.extent	7	es
dc.identifier.citation	Neurología (English Edition), 2012, Vol. 27 (1), pp. 4-10
dc.identifier.doi	https://doi.org/10.1016/j.nrleng.2011.03.005
dc.identifier.issn	Print: 2173-5808
dc.identifier.uri	http://hdl.handle.net/10201/143400
dc.language	eng	es
dc.publisher	Elsevier	es
dc.relation	Sin financiación externa a la Universidad	es
dc.relation.publisherversion	https://www.sciencedirect.com/science/article/pii/S2173580812000090
dc.rights	info:eu-repo/semantics/openAccess	es
dc.rights	Attribution-NonCommercial-NoDerivatives 4.0 Internacional	*
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/4.0/	*
dc.subject	Quality of life	es
dc.subject	Alzheimer’s disease	es
dc.subject	QoL-AD scale	es
dc.subject	Validation	es
dc.title	Validation of the Spanish version of the QoL-AD scale in Alzheimerdisease patients, their carers, and health professionals.	es
dc.type	info:eu-repo/semantics/article	es
dspace.entity.type	Publication	es
relation.isAuthorOfPublication	44278cfb-f559-47b0-950d-fdecaf73adf3
relation.isAuthorOfPublication.latestForDiscovery	44278cfb-f559-47b0-950d-fdecaf73adf3